Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

hromosome 17p.

The Breakthrough Therapy Designation is intended to expedite the development and review of a potential new drug for serious or life-threatening diseases where "preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development." The designation of a drug as a Breakthrough Therapy was enacted as part of the 2012 Food and Drug Administration Safety and Innovation Act. Pharmacyclics, together with Janssen, is working with the FDA to determine the implications of this Breakthrough Therapy Designation to the ongoing and planned development and the filing requirements for the use of ibrutinib in patients. At this time Pharmacyclics is targeting to submit the MCL filing before the end of the third quarter 2013. Pharmacyclics anticipates to provide guidance prior to year end on the WM and CLL with deletion 17p filing timelines after further discussions with the FDA.

The FDA Breakthrough Therapy Designations for ibrutinib were based on data from clinical and pre-clinical studies. Ibrutinib has the potential to improve the outcome in these serious and life-threatening diseases which have a poor prognosis. The company and its collaboration partner, Janssen, have designed and are currently executing a development program for ibrutinib in each of these indications.

Comprehensive Pre-Clinical Research and Clinical Development To broaden our understanding of ibrutinib, Pharmacyclics has performed research into mechanisms of action both in its own research department, and through collaborations with leading universities and clinical centers. Over the past 3 years, Pharmacyclics' research department has established and maintained 47 collaborations with academic investigators at universities or clinical centers. This broad-reaching collaborative effort has resulted
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015 Biosimilars are not ... the U.S. Food and Drug Administration (FDA) for ... in its draft guidance issued today. The FDA,s ... proposes distinguishable names, calling for biological products to ... suffix. This proposal reflects the agency,s thinking that ...
(Date:8/27/2015)... -- Eli Lilly and Company (NYSE: LLY ) will ... September 17, 2015. Sue Mahony , Ph.D., senior ... Richard Gaynor , M.D., senior vice president of product ... in a fireside chat at 3:30 p.m., Eastern Daylight ... be available on the "Webcasts & Presentations" section of ...
(Date:8/27/2015)... Ala. , Aug. 27, 2015 /PRNewswire/ ... Outpatient Pharmacy Provider (IOPP™) is expanding its ... of a medication-focused transition of care program ... named "RxCare Management," provides hospitals with technology ... hospital performance measures that have been mandated ...
Breaking Medicine Technology:Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Lilly to Participate in Morgan Stanley Global Healthcare Conference 2Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
(Date:8/28/2015)... Angeles, CA (PRWEB) , ... August 28, 2015 , ... ... endless journey that local pizza maker Paul LaRocco has gone through to open a ... city approval and permitting process tends to take several months, but the current process, ...
(Date:8/28/2015)... ... , ... The 6th Annual Survivor in the City, Chicago silent auction ... accolade to its cadre of widespread support—an official letter of support and gratitude from ... medical community and the University of Illinois at Chicago’s Department of Neurosurgery, the Brain ...
(Date:8/28/2015)... Chicago,IL (PRWEB) , ... August 28, 2015 , ... ... Stencils Device Library for documenting and diagramming network and data center assets and ... Manufacturer / Device Model, Cisco Nexus 5000 Series, HP ProLiant Gen9, EMC VNX ...
(Date:8/28/2015)... , ... August 28, 2015 , ... Dr. Gregory K. ... as radiating pain resulting in shoulder pain, hip pain, neck pain, stiffness, ... Civil Engineering from the University of Illinois, and then went on to earn his ...
(Date:8/28/2015)... Newton, Mass. (PRWEB) , ... August 28, 2015 ... ... is proud to announce its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia ... Bar™ brewer. It features revolutionary Thermal Flavor Extraction™ technology, which delivers a variety ...
Breaking Medicine News(10 mins):Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... study estimates that 1 of every 91 children is affected, ... has suggested that the prevalence of autism spectrum disorders in ... new government study estimates that the prevalence is more likely ... which is published in the October issue of Pediatrics ...
... , The Autism Research Institute (ARI) states that ... are amenable to treatment; hundreds of parents, researchers, and ... and treatment options at this weekend,s ARI/Defeat Autism Now! ... The National Children,s Health Survey published results from ...
... ... Disability insurance provider Set for Life Insurance by KF Financial, ... . The website is a refreshing break from typical insurance websites ... artwork and life insurance quotes. Set for Life Insurance is nationally ...
... the compound that gives curry powder its yellow/orange color, may ... and neck cancer who continue to smoke. In a ... Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO ... on head and neck squamous cell carcinoma (HNSCC) growths. The ...
... blood-thinning drug who starts bleeding more than expected, and an ... antidote were designed to work together. Researchers at Duke University ... an entire, versatile class of drugs called aptamers and published ... anticoagulant, you are trying to reduce your chances of having ...
... Some see chance to steer them towards local elder services, ... can do more than make their clients look good, they ... health-care services they need, an Ohio State University study suggests. ... Ohio-area found that most develop long-term relationships with their older ...
Cached Medicine News:Health News:Autism May Be More Common Than Thought 2Health News:Autism May Be More Common Than Thought 3Health News:New Government Research Finds One in Every 100 Children Has Autism, of Whom Nearly 40% Are Recovered 2Health News:New Website for Disability Insurance Launched by Set for Life Insurance by KF Financial 2Health News:Designing drugs and their antidotes together improves patient care 2Health News:Designing drugs and their antidotes together improves patient care 3Health News:Hairstylists Often Privy to Older Clients' Health Issues 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: